Innovation
15 patent families (1 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace accelerating. Cited 819 times.
| Year | Filings |
|---|---|
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 3 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 3 |
| 2023 | 4 |
| 2024 | 10 |
| 2025 | 11 |
| 2026 | 4 |
Social engagement
Social engagement: 4.5K social following, 10 posts in the last 12 months — below the industry typical range.
Investor mix
20 investors on record; lead investors include Novartis, Johnson & Johnson Innovation – JJDC, Bios Partners, InFocus Capital Partners.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 12 | 60% |
| Private equity | 1 | 5% |
| Angel & family office | 2 | 10% |
| Other / undisclosed | 5 | 25% |